Popular Articles
Natural Remedies

Metabolic Solutions Development Company Announces Preliminary Results From Phase IIa Clinical Trial
Metabolic Solutions Development Company (MSDC) announced that its lead compound, MSDC-0160, can improve insulin sensitivity and lower blood glucose levels in humans without the side effects of current therapies when taken over a 28-day period, according to preliminary data derived from the company"s Phase IIa clinical trial.
generic viagra online
Editorials, Opinion Pieces Respond To Recent Action On Health Reform
The following summarizes recent editorials and opinion pieces responding to health reform action over the last week.
News of the day
Reliv International's GlucAffect(TM) Proven Effective In Clinical Study
A clinical study published in the journal Phytotherapy Research found that GlucAffect, a nutritional supplement developed by Reliv International, Inc. (Nasdaq: RELV), significantly reduced blood glucose levels and helped control weight in study participants.
Sexual Health

Genetic Defects Linked With Rare Bearded Lady

New research provides exciting genetic insight into a rare syndrome that first appeared in the medical literature in the mid 1800s with the case of Julia Pastrana, the world"s most notorious bearded lady. The study, published by Cell Press in the May 21st issue of the American Journal of Human Genetics, reveals intriguing molecular clues about the pathogenesis of this mysterious condition that has captured the attention of the public since the Middle Ages. Congenital generalized hypertrichosis (CGH) represents a group of conditions characterized by excessive hair growth over the entire body, well beyond the average limits for a particular age, sex or race. Congenital generalized hypertrichosis terminalis (CGHT) with gingival hypertrophy is a distinct subgroup of CGH that is associated with universal overgrowth of darkly pigmented hairs, enlarged gums and a distortion of facial features, the phenotype famously exhibited by Julia Pastrana. "Although it has long been believed that most people with CGH have some kind of genetic defect, the specific genetic mutations that underlie CGHT, with or without gingival hyperplasia, had not been discovered until now," explains senior study author Dr. Xue Zhang from the Chinese Academy of Medical Sciences and Peking Union Medical College in Beijing. The condition has been very difficult to study because it is so rare. Dr. Zhang and colleagues performed a sophisticated, high resolution genetic analysis of several members of three Chinese families with CGHT and an individual with a sporadic case of CGHT with gingival hyperplasia. The researchers mapped the genetic locus for this syndrome and discovered that genetic defects on chromosome 17q24.2-q24.3 were responsible for CGHT with or without gingival hyperplasia. The three families exhibited different DNA deletions whereas the sporadic case was associated with a DNA duplication within the identified chromosome region. These different copy number mutations affected 4 to 8 genes. "Our work clearly establishes CGHT as a genomic disorder. However, further studies are needed to elucidate the exact molecular mechanisms by which copy number mutations on 17q24.2-q24.3 lead to the defining characteristics of this rare disorder," concludes Dr. Zhang. Cathleen Genova Cell Press


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):